Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Mimedx (MDXG) over the last 9 years, with Q3 2025 value amounting to $16.8 million.

  • Mimedx's Non-Current Debt fell 654.35% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 million, marking a year-over-year decrease of 654.35%. This contributed to the annual value of $17.8 million for FY2024, which is 6293.06% down from last year.
  • Per Mimedx's latest filing, its Non-Current Debt stood at $16.8 million for Q3 2025, which was down 654.35% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Non-Current Debt registered a high of $49.0 million during Q3 2023, and its lowest value of $16.8 million during Q3 2025.
  • Its 5-year average for Non-Current Debt is $37.1 million, with a median of $48.0 million in 2021.
  • As far as peak fluctuations go, Mimedx's Non-Current Debt surged by 101.29% in 2023, and later crashed by 6320.3% in 2024.
  • Mimedx's Non-Current Debt (Quarter) stood at $48.1 million in 2021, then increased by 0.97% to $48.6 million in 2022, then dropped by 1.02% to $48.1 million in 2023, then tumbled by 62.93% to $17.8 million in 2024, then dropped by 5.56% to $16.8 million in 2025.
  • Its last three reported values are $16.8 million in Q3 2025, $17.2 million for Q2 2025, and $17.5 million during Q1 2025.